Document Detail


Characterization of Plasmodium liver stage inhibition by halofuginone.
MedLine Citation:
PMID:  22438279     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Malaria is a devastating parasitic disease that afflicts one-third of the world's population. Antimalarial drugs in common use address few targets, and their efficacy is being undermined by parasite resistance. Most therapeutics target blood-stage malaria, whereas only few compounds are active against malaria's liver stage, the first stage of the Plasmodium parasite's life cycle within the human host. The identification of inhibitors active against liver-stage malaria would benefit the development of chemical probes to elucidate the poorly understood biology of this phase of the parasite life cycle and could provide agents to prevent and eliminate the disease. Herein we report the development of a live-cell parasite traversal assay in 384-well format amenable to high-throughput screening that exploits the wounding of liver cells by the parasite. This method identifies small molecules that may inhibit the parasite's actin-myosin motor system. The traversal assay, in addition to established methods, was used to evaluate the activity of halofuginone, a synthetic halogenated derivative of the natural alkaloid febrifugine, against liver-stage Plasmodium berghei parasites. Halofuginone was found to inhibit P. berghei sporozoite load in HepG2 cells with an IC(50) value of 17 nM. While the compound does not affect parasite traversal through human liver cells, an inhibition time course assay indicates that it affects essential processes in both early- and late-stage parasite development.
Authors:
Emily R Derbyshire; Ralph Mazitschek; Jon Clardy
Related Documents :
22692509 - The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestrati...
12496009 - Neutrophils movement in vitro.
8842809 - Pc12 cell aggregation and neurite growth in gels of collagen, laminin and fibronectin.
21105169 - Genipin-crosslinked microcarriers mediating hepatocellular aggregates formation and fun...
22760199 - Sensitization of glioma cells by x-linked inhibitor of apoptosis protein knockdown.
20654429 - Evaluation of the teratogenic potential of valproic acid analogues in transgenic dictyo...
12089449 - Systematic identification of pathways that couple cell growth and division in yeast.
11982759 - Ultraviolet-b-induced g1 arrest is mediated by downregulation of cyclin-dependent kinas...
23379909 - Silencing satb1 with sirna inhibits the proliferation and invasion of small cell lung c...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-03-21
Journal Detail:
Title:  ChemMedChem     Volume:  7     ISSN:  1860-7187     ISO Abbreviation:  ChemMedChem     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-04-25     Completed Date:  2012-08-22     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  101259013     Medline TA:  ChemMedChem     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  844-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Affiliation:
Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antimalarials / chemistry,  pharmacology
Cell Line, Tumor
Cytokinesis
High-Throughput Screening Assays / methods
Humans
Inhibitory Concentration 50
Liver / drug effects*,  parasitology
Malaria / drug therapy*
Mice
Models, Biological
Piperidines / chemistry,  pharmacology*
Plasmodium berghei*
Plasmodium falciparum*
Quinazolinones / chemistry,  pharmacology*
Sporozoites / physiology
Structure-Activity Relationship
Grant Support
ID/Acronym/Agency:
F32 GM093510/GM/NIGMS NIH HHS; F32GM093510/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/Antimalarials; 0/Piperidines; 0/Quinazolinones; L31MM1385E/halofuginone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enhancement of DNA vaccine efficacy by targeting the xenogeneic hCG, survivin and VEGFR 2 combined t...
Next Document:  The right inhibition? Callosal correlates of hand performance in healthy children and adolescents ca...